Global Stem Cell Market to Reach USD 46.91 billion by 2032, Aided by the Rising Prevalence of Chronic Diseases

The market for stem cell is being driven by the rising prevalence of various health-related issues. As orthopaedic injuries and trauma cases caused by accidents are significantly surging, stem cell therapy is being deployed in the treatment of various bone-joint injuries, such as femoral head, osteogenesis imperfecta, and spinal bone defects, among others, which is augmenting the market growth. Moreover, increasing research and development (R&D) activities to deploy stem cell therapy as a potential treatment for arthritis and osteoporosis is expected to drive the market growth. In addition, various measures undertaken by both governments and other organisations to increase the awareness regarding the benefits of stem cell is projected to propel the market growth.

Some of the leading players in the market are Becton, Dickinson and Company (NYSE: BDX) and Cellular Engineering Technologies. In November 2018, the latter, along with John Paul II Medical Research Institute and the University of Iowa, announced a new milestone in regenerative medicine to create safer pluripotent stem cells from cord blood and peripheral blood obtained from donors. The findings examined a new approach to create induced pluripotent stem cells (iPSC) without utilising viruses and standard oncogenes. The study demonstrated the creation of iPSC from peripheral blood in patients with Cystic Fibrosis and alpha one antitrypsin deficiency, a cause of Chronic Obstructive Pulmonary Disease. It also provided a safer autologous pluripotent stem cell for future use as the technology can provide personalised and regenerative medicine, drug discovery, and bio-banking. Such research and studies to discover advanced and innovative methods are expected to augment the market growth in the coming years.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Product Type, Treatment Type, Application, and Region:

• The market, on the basis of product type, can be divided into adult stem cell, human embryonic cell, and pluripotent stem cell, among others.

• Based on treatment types, the industry can be divided into allogeneic stem cell therapy, autologic stem cell therapy, and syngeneic stem cell therapy.

• The major applications of stem cell include neurological disorders, orthopaedic treatments, oncology disorders, injuries and wounds, and cardiovascular disorders, among others.

• The regional markets for stem cell include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The increasing utilisation of human-induced pluripotent stem cells (iPSCs) for the treatment of various neurological disorders, inherited heart complications, and genetic diseases are propelling the market growth.

• The market is being aided by the rising demand for regenerative medicines, which is increasing the demand for stem cells owing to their therapeutic properties.

• The increasing research activities for the treatment of various diseases, such as age-related macular degeneration (AMD), are augmenting the growth of the stem cell industry.

• The integration of various technologies, such as artificial intelligence (AI), machine learning, and blockchain, to eliminate errors during research activities is further invigorating the market growth of stem cell.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for stem cell for the periods (2018-2023) and (2024-2032).

• The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the product types, treatment types, applications, and major regions of stem cell.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global stem cell market are Pluristem Therapeutics Inc., Thermo Fisher Scientific Inc., Cellular Engineering Technologies, Merck KGaA, Becton, Dickinson and Company, and STEMCELL Technologies Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.